Literature DB >> 6481182

Activation of the alternative complement pathway by Fonsecaea pedrosoi.

W Torinuki, K Okohchi, H Takematsu, H Tagami.   

Abstract

Human sera were examined for evidence of complement activation by Fonsecaea pedrosoi. The serum that had been incubated with F. pedrosoi showed immunoelectrophoretic C3 conversion and generation of C5a, as measured by radioimmunoassay. C3 conversion and C5a generation did not occur in serum chelated with EDTA, or in serum heated to 56 degrees C for 30 min. Serum depleted of the heat (50 degrees C X 30 min)-labile factor B was also deficient in C3 conversion and C5a generation. Complement activation was not affected when the classical pathway was blocked by Mg++-EGTA. These studies indicate that F. pedrosoi can activate the complement system via the alternative pathway, with the resultant development of C5a.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481182     DOI: 10.1111/1523-1747.ep12340435

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  The effect of the supernatants obtained from Sporothrix schenkii and Candida albicans culture on the generation of reactive oxygen species by polymorphonuclear leukocytes.

Authors:  A Yoshioka; Y Miyachi; S Imamura; Y Niwa
Journal:  Mycopathologia       Date:  1987-10       Impact factor: 2.574

2.  Complement activation by Sporothrix schenckii.

Authors:  W Torinuki; H Tagami
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 3.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

4.  Activation of the alternative complement pathway by Sporothrix schenckii.

Authors:  E N Scott; H G Muchmore; D P Fine
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

5.  Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system.

Authors:  Lysianne Pinto; Luiz Fernando Zmetek Granja; Mariana Amorim de Almeida; Daniela Sales Alviano; Maria Helena da Silva; Regina Ejzemberg; Sonia Rozental; Celuta Sales Alviano
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-06-25       Impact factor: 2.743

Review 6.  Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis.

Authors:  Leandro C D Breda; Isabela G Menezes; Larissa N M Paulo; Sandro Rogério de Almeida
Journal:  J Fungi (Basel)       Date:  2020-12-22

Review 7.  Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.

Authors:  Luiz Felipe Domingues Passero; Italo Novais Cavallone; Walter Belda
Journal:  J Immunol Res       Date:  2021-11-01       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.